Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001455244-09-000048
Filing Date
2009-05-27
Accepted
2009-05-27 16:51:13
Documents
1
Period of Report
2009-05-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3794
  Complete submission text file 0001455244-09-000048.txt   5810
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O XOMA, LTD. 2910 SEVENTH STREET BERKELEY CA 94710
Business Address
DAVIS PETER B (Reporting) CIK: 0001222789 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 09854918